CIK: 0001493215 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 28, 2018
Total Value ($000): $599,105 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 4,130,115 | $68,890 | 11.5% | $13.46 | +25.7% | COM | 69366J200 |
| RGNX | Regenxbio Inc | 1,561,210 | $51,910 | 8.7% | $20.73 | +45.4% | COM | 75901B107 |
| BMY | Bristol-Myers Squibb Co | 839,452 | $51,442 | 8.6% | $42.11 | +10.3% | COM | 110122108 |
| ALNY | Alnylam Pharmaceuticals Inc | 358,774 | $45,582 | 7.6% | $75.05 | +67.4% | COM | 02043Q107 |
| — | Dicerna Pharmaceuticals Inc | 5,035,662 | $44,142 | 7.4% | $10.56 | — | COM | 253031108 |
| — | Achillion Pharmaceuticals Inc | 13,546,902 | $39,015 | 6.5% | $3.82 | — | COM | 00448Q201 |
| — | La Jolla Pharmaceutical Co | 1,063,170 | $34,213 | 5.7% | $25.47 | — | COM PAR $.0001 2 | 503459604 |
| — | Avexis Inc | 281,242 | $31,125 | 5.2% | $33.55 | — | COM | 05366U100 |
| ABUS | Arbutus Biopharma Corp | 5,151,615 | $26,016 | 4.3% | $3.27 | +79.5% | COM | 03879J100 |
| — | Global Blood Therapeutics Inc | 601,683 | $23,676 | 4.0% | $39.19 | — | COM | 37890U108 |
| OSUR | OraSure Technologies Inc | 878,452 | $16,568 | 2.8% | $13.47 | +34.5% | COM | 68554V108 |
| BCRX | BioCryst Pharmaceuticals Inc | 3,372,674 | $16,560 | 2.8% | $7.22 | -32.9% | COM | 09058V103 |
| — | Corium International Inc | 1,699,653 | $16,334 | 2.7% | $7.97 | — | COM | 21887L107 |
| — | Agenus Inc | 4,329,816 | $14,115 | 2.4% | $7.48 | — | COM NEW | 00847G705 |
| EW | Edwards Lifesciences Corp | 123,000 | $13,863 | 2.3% | $36.70 | 0.0% | COM | 28176E108 |
| VRAYQ | Viewray Inc | 1,348,210 | $12,484 | 2.1% | $6.34 | +26.3% | COM | 92672L107 |
| — | Myokardia Inc | 257,663 | $10,848 | 1.8% | $42.84 | — | COM | 62857M105 |
| MASI | Masimo Corp | 120,900 | $10,252 | 1.7% | $66.53 | +30.4% | COM | 574795100 |
| — | Atara Biotherapeutics Inc | 556,118 | $10,066 | 1.7% | $17.06 | — | COM | 046513107 |
| — | Proteostasis Therapeutics Inc | 1,500,000 | $8,745 | 1.5% | $5.83 | — | COM | 74373B109 |
| — | Viveve Medical Inc | 1,672,998 | $8,315 | 1.4% | $4.99 | — | COM NEW | 92852W204 |
| QURE | Uniqure NV | 403,524 | $7,905 | 1.3% | $15.23 | 0.0% | SHS | N90064101 |
| VCEL | Vericel Corp | 1,304,801 | $7,111 | 1.2% | $4.61 | 0.0% | COM | 92346J108 |
| — | Odonate Therapeutics Inc | 297,555 | $6,768 | 1.1% | $22.75 | — | COM | 676079106 |
| TCMD | Tactile Systems Technology Inc | 210,366 | $6,096 | 1.0% | $17.26 | +68.1% | COM | 87357P100 |
| — | Oxford Immunotec Global PLC | 375,792 | $5,250 | 0.9% | $15.20 | — | ORD SHS | G6855A103 |
| — | Bovie Medical Corp | 1,752,611 | $4,557 | 0.8% | $3.11 | — | COM | 10211F100 |
| — | Zynerba Pharmaceuticals Inc | 202,859 | $2,540 | 0.4% | $8.42 | — | COM | 98986X109 |
| — | Five Prime Therapeutics Inc | 100,377 | $2,200 | 0.4% | $21.92 | — | COM | 33830X104 |
| ARGX | argenx NV | 25,260 | $1,595 | 0.3% | $21.81 | — | SPONSORED ADR | 04016X101 |
| — | Revance Therapeutics Inc | 23,038 | $824 | 0.1% | $35.77 | — | COM | 761330109 |
| — | SENSUS HEATLHCARE INC | 151,400 | $98 | 0.0% | $0.50 | — | *W EXP 06/08/201 | 81728J117 |